天堂网亚洲,天天操天天搞,91视频高清,菠萝蜜视频在线观看入口,美女视频性感美女视频,95丝袜美女视频国产,超高清美女视频图片

Canakinumab

Canakinumab Struktur
914613-48-2
CAS-Nr.
914613-48-2
Englisch Name:
Canakinumab
Synonyma:
ACZ885;Ilaris;ACZ-885;ACZ 885;Canakinumab;ACZ 885|||Ilaris;Canakinumab (Anti-IL-1b);Research Grade Canakinumab;Anti-Human IL-1B(Canakinumab);Research Grade Canakinumab(DHB95601)
CBNumber:
CB24845962
Summenformel:
Molgewicht:
0
MOL-Datei:
Mol file

Canakinumab Eigenschaften

storage temp. 
Store at -20°C
Aggregatzustand
Liquid
Farbe
Colorless to light yellow

Sicherheit

Canakinumab Chemische Eigenschaften,Einsatz,Produktion Methoden

Canakinumab Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

Canakinumab Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.

Global( 27)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Aladdin Scientific
tp@aladdinsci.com United States 57505 58
Chembest Research Laboratories Limited +86-21-20908456
sales@BioChemBest.com China 6005 61
BOC Sciences 1-631-485-4226; 16314854226
 info@bocsci.com United States 12952 65
Shanghai EFE Biological Technology Co., Ltd. 021-65675885 18964387627
 info@efebio.com China 9803 58
Shanghai YuanYe Biotechnology Co., Ltd. 021-61312847; 18021002903
 3008007409@qq.com China 71826 60
ShangHai Biochempartner Co.,Ltd 17754423994 17754423994
 2853530910@QQ.com China 7989 62
Guangzhou Hongyuan Chemical Co.,Ltd 15817493340
 981810490@qq.com China 1566 58
Wuhan Chemstan Biotechnology Co., Ltd. 027-65317797 15926423062
 422450190@qq.com China 10308 58
Hubei Kele Fine Chemical Co., Ltd 027-59101668 19945030958
 2881924765@qq.com China 7997 58
Bide Pharmatech Ltd. 400-1647117 13681763483
 product02@bidepharm.com China 62321 58
  • Canakinumab
  • Anti-Human IL-1B(Canakinumab)
  • Research Grade Canakinumab(DHB95601)
  • ACZ 885
  • ACZ885
  • ACZ-885
  • Ilaris
  • Canakinumab (Anti-IL-1b)
  • ACZ 885|||Ilaris
  • Research Grade Canakinumab
  • Canakinumab - in PBS buffer approx. 15mg/ml
  • 914613-48-2
Copyright 2019 ? ChemicalBook. All rights reserved